American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (5th edn). Arlington, VA: American Psychiatric Publishing.
Google Scholar | Crossref Baeken, C, Duprat, R, Wu, G-R, et al. (2017) Subgenual anterior cingulate–medial orbitofrontal functional connectivity in medication-resistant major depression: A neurobiological marker for accelerated intermittent theta burst stimulation treatment? Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2(7): 556–565.
Google Scholar | Crossref | Medline Bergman, H, Källmén, H, Rydberg, U, et al. (1994) Audit. The Alcohol Use Disorder Identification Test Manual, Swedish Version. Solna: Karolinska Institutet.
Google Scholar Berman, AH, Bergman, H, Palmstierna, T, et al. (2005) Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research 11(1): 22–31.
Google Scholar | Crossref | Medline | ISI Blumberger, DM, Vila-Rodriguez, F, Thorpe, KE, et al. (2018) Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): A randomised non-inferiority trial. The Lancet 391(10131): 1683–1692.
Google Scholar | Crossref | Medline Bodén, R, Bengtsson, J, Thörnblom, E, et al. (2021) Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression—a randomized controlled trial. Journal of Affective Disorders 290: 308–315.
Google Scholar | Crossref | Medline Bozymski, KM, Potter, TG, Venkatachalam, V, et al. (2018) Caffeine sodium benzoate for electroconvulsive therapy augmentation. The Journal of ECT 34(4): 233–239.
Google Scholar | Crossref | Medline Coelho, JE, Alves, P, Canas, PM, et al. (2014) Overexpression of adenosine A2A receptors in rats: Effects on depression, locomotion, and anxiety. Frontiers in Psychiatry 5: 67.
Google Scholar | Crossref | Medline Cole, EJ, Stimpson, KH, Bentzley, BS, et al. (2020) Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression. American Journal of Psychiatry 177(8): 716–726.
Google Scholar | Crossref | Medline Crema, LM, Pettenuzzo, LF, Schlabitz, M, et al. (2013) The effect of unpredictable chronic mild stress on depressive-like behavior and on hippocampal A1 and striatal A2A adenosine receptors. Physiology & Behavior 109: 1–7.
Google Scholar | Crossref | Medline Cusin, C, Iovieno, N, Iosifescu, DV, et al. (2013) A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry 74(7): e636–e641.
Google Scholar | Crossref | Medline DeRubeis, RJ, Hollon, SD, Amsterdam, JD, et al. (2005) Cognitive therapy vs. Medications in the treatment of moderate to severe depression. Archives of General Psychiatry 62(4): 409–416.
Google Scholar | Crossref | Medline Downar, J, Daskalakis, ZJ (2013) New targets for rTMS in depression: A review of convergent evidence. Brain Stimulation 6(3): 231–240.
Google Scholar | Crossref | Medline Dunlop, K, Sheen, J, Schulze, L, et al. (2020) Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial. Brain Stimulation 13(2): 337–340.
Google Scholar | Crossref | Medline Enomoto, H, Terao, Y, Kadowaki, S, et al. (2015) Effects of l-Dopa and pramipexole on plasticity induced by QPS in human motor cortex. Journal of Neural Transmission 122(9): 1253–1261.
Google Scholar | Crossref | Medline Ferré, S, Quiroz, C, Woods, AS, et al. (2008) An update on adenosine A2A-dopamine D2 receptor interactions. Implications for the function of G protein-coupled receptors. Current Pharmaceutical Design 14(15): 1468–1474.
Google Scholar | Crossref | Medline Frary, CD, Johnson, RK, Wang, MQ (2005) Food sources and intakes of caffeine in the diets of persons in the United States. Journal of the American Dietetic Association 105(1): 110–113.
Google Scholar | Crossref | Medline Fredholm, BB, Chen, J-F, Cunha, RA, et al. (2005) Adenosine and brain function. International Review of Neurobiology 63: 191–270.
Google Scholar | Crossref | Medline | ISI Halahakoon, DC, Kieslich, K, O’Driscoll, C, et al. (2020) Reward-processing behavior in depressed participants relative to healthy volunteers: A systematic review and meta-analysis. JAMA Psychiatry 77: 1286–1295.
Google Scholar | Crossref | Medline Hill, DF, Parent, KL, Atcherley, CW, et al. (2018) Differential release of dopamine in the nucleus accumbens evoked by low-versus high-frequency medial prefrontal cortex stimulation. Brain Stimulation 11(2): 426–434.
Google Scholar | Crossref | Medline Hunter, AM, Minzenberg, MJ, Cook, IA, et al. (2019) Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of major depressive disorder. Brain and Behavior 9(5): e01275.
Google Scholar | Crossref | Medline Kaster, MP, Machado, NJ, Silva, HB, et al. (2015) Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proceedings of the National Academy of Sciences 112(25): 7833–7838.
Google Scholar | Crossref | Medline Kessler, RC, Petukhova, M, Sampson, NA, et al. (2012) Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International Journal of Methods in Psychiatric Research 21(3): 169–184.
Google Scholar | Crossref | Medline | ISI Lazarus, M, Shen, H-Y, Cherasse, Y, et al. (2011) Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. Journal of Neuroscience 31(27): 10067–10075.
Google Scholar | Crossref | Medline Llerena, K, Park, SG, McCarthy, JM, et al. (2013) The Motivation and Pleasure Scale–Self-Report (MAP-SR): Reliability and validity of a self-report measure of negative symptoms. Comprehensive Psychiatry 54(5): 568–574.
Google Scholar | Crossref | Medline Lopez-Cruz, L, Salamone, JD, Correa, M (2018) Caffeine and selective adenosine receptor antagonists as new therapeutic tools for the motivational symptoms of depression. Frontiers in Pharmacology 9: 526.
Google Scholar | Crossref | Medline Lucas, M (2011) Coffee, caffeine, and risk of depression among women. Archives of Internal Medicine 171(17): 1571.
Google Scholar | Crossref | Medline Månsson, KNT, Lueken, U, Frick, A (2021) Enriching CBT by neuroscience: Novel avenues to achieve personalized treatments. International Journal of Cognitive Therapy 14: 182–195.
Google Scholar | Crossref Nehlig, A (2018) Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacological Reviews 70(2): 384–411.
Google Scholar | Crossref | Medline Nestler, EJ, Carlezon, WA (2006) The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 59(12): 1151–1159.
Google Scholar | Crossref | Medline | ISI Ortiz, R, Ulrich, H, Zarate, CA, et al. (2015) Purinergic system dysfunction in mood disorders: A key target for developing improved therapeutics. Progress in Neuro-Psychopharmacology and Biological Psychiatry 57: 117–131.
Google Scholar | Crossref | Medline Pary, R, Scarff, JR, Jijakli, A, et al. (2015) A review of psychostimulants for adults with depression. Federal Practitioner 32(Suppl. 3): 30S–37S.
Google Scholar | Medline Rush, AJ, Trivedi, MH, Wisniewski, SR, et al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry 163(11): 1905–1917.
Google Scholar | Crossref | Medline | ISI Sehatzadeh, S, Daskalakis, ZJ, Yap, B, et al. (2019) Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: A meta-analysis of randomized controlled trials over 2 decades. Journal of Psychiatry & Neuroscience: JPN 44(3): 151–163.
Google Scholar | Crossref | Medline Sheehan, DV, Lecrubier, Y, Sheehan, KH, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 59 (Suppl. 20): 22–33.
Google Scholar | Medline | ISI Smith, AP (2009) Caffeine, cognitive failures and health in a non-working community sample. Human Psychopharmacology: Clinical and Experimental 24(1): 29–34.
Google Scholar | Crossref | Medline Svanborg, P, Åsberg, M (1994) A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatrica Scandinavica 89(1): 21–28.
Google Scholar | Crossref | Medline Szopa, A, Poleszak, E, Wyska, E, et al. (2016) Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn-Schmiedeberg’s Archives of Pharmacology 389: 211–221.
Google Scholar | Crossref | Medline Whiteford, HA, Degenhardt, L, Rehm, J, et al. (2013) Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. The Lancet 382(9904): 1575–1586.
Google Scholar | Crossref | Medline | ISI Wise, RA, Rompre, P-P (1989) Brain dopamine and reward. Annual Review of Psychology 40(1): 191–225.
Google Scholar | Crossref | Medline Yacoubi, ME, Ledent, C, Parmentier, M, et al. (2009) Adenosine A2A receptor antagonists are potential antidepressants: Evidence based on pharmacology and A2A receptor knockout mice. British Journal of Pharmacology 134(1): 68–77.
Google Scholar | Crossref Yamada, K, Kobayashi, M, Kanda, T (2014) Chapter fifteen–Involvement of adenosine A2A receptors in depression and anxiety. In: A, Mori (ed.) International Review of Neurobiology. Adenosine Receptors in Neurology and Psychiatry. New York: Academic Press, pp.373–393.
Google Scholar | Crossref